PP KONEX TRADE DATA ANALYSIS
Access comprehensive trade data for Pp Konex with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Pp Konex – Overview
Eximpedia analyzes Pp Konex export and import records, including data from 0 buyers and 6 suppliers. We provide an intelligence report of Pp Konex that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Pp Konex Buyers, Suppliers & Shipments
Pp Konex import markets
Explore the Pp Konex import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004900000 | 2.46 | 93 | 45.59 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004490000 | 1.75 | 10 | 4.90 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004500000 | 1.55 | 10 | 4.90 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004320000 | 1.47 | 28 | 13.73 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 2106909890 | 0.16 | 16 | 7.84 |
| FOOD PREPARATIONS NOT ELSEWHERE SPECIFIED OR INCLUDED | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| GERMANY | 3.34 | 27 | 13.24 |
| EUROPEAN UNION | 2.23 | 85 | 41.67 |
| SWEDEN | 1.43 | 37 | 18.14 |
| UNITED STATES | 0.46 | 17 | 8.33 |
| PUERTO RICO | 0.13 | 17 | 8.33 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA100200 | 5.38 | 106 | 51.96 |
| UA401020 | 2.26 | 90 | 44.12 |
| UA100110 | 0.04 | 8 | 3.92 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| MINISTRY OF HEALTH | 206.51 | 8344 |
| SOCIAL SECURITY INSTITUTION | 231.08 | 35 |
| BADM LIMITED LIABILITY COMPANY | 394.73 | 5166 |
| JV OPTIMA FARM LIMITED | 400.43 | 5786 |
| TURKISH PHARMACISTS ASSOCIATION ECONOMIC ENTERPRISE | 536.15 | 2196 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| TANNER PHARMA CH GMBH ON BEHALF OF MAXAID | 117.29 | 15 |
| BIOGEN INTERNATIONAL GMBH | 127.48 | 115 |
| BOEHRINGER INGELHEIM | 146.49 | 839 |
| BMED INTERNATIONAL BUSINESS COMPANY LIMITED | 150.27 | 163 |
| GEN ILAÇ INTERNATIONAL TRADING LIMITED | 244.44 | 236 |
If you are looking to establish relationship with Pp Konex Automation you can save time by getting access to the key decision makers and get a detailed report.
Pp Konex Import Shipments
Discover the Pp Konex with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3004320000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, CONTAINING CORTICOSTEROID HORMONES, PACKAGED FOR RETAIL SALE: - SYMBIKORT TURBUCHALER, POWDER FOR INHALATION, DOSED, 160 MCG/4.5 MCG/DOSE OF 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 INHALATION (DOSE) CONTAINS: 160 MCG OF MICRONIZED BUDESONIDE, 4.5 MCG OF FORMOTEROL FUMARATE DIHYDRATE) SERIES: XLGZ - 400 UNITS MANUFACTURER: ""ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADE MARK: ASTRAZENECA-BUDESONIDE ASTRAZENECA, SUSPENSION FOR SPRAYING, 0.5 MG/ML, 2 ML IN A CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 ML SUSPENSION FOR SPRAYING CONTAINS: 0.5 MG BUDESONIDE) SERIES: PECN-100UP MANUFACTURER: ""PRODUCTION, QUALITY CONTROL AND RELEASE OF THE SERIES: ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADE MARK: ASTRAZENECA """ |  |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - BRILINTA, FILM-COATED TABLETS, 90 MG, 14 TABLETS IN A BLISTER PACK; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: TICAGRELOR 90 MG) SERIES: VHNS-90UP MANUFACTURER: ""ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADE MARK: ASTRAZENECA" | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - FORXIGA, FILM-COATED TABLETS, 10 MG, 10 TABLETS IN A BLISTER; 3 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET, COVERED WITH A FILM COVER, CONTAINS: 12.30 MG OF DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE IN THE CALCULATION OF NADAPAGLIFLOZIN 10 MG) SERIES: SJ275 -450 UNITS MANUFACTURER: """"MANUFACTURER """"IN BULK"""": ASTRAZENECA PHARMACEUTICALS LP, USA; PRODUCTION, RESP. FOR: MON. AND MON. PACKAGING, SERIES RELEASE: ASTRAZENECA UK LIMITED, GREAT BRITAIN; QUALITY CONTROL: ASTRAZENECA AB, SWEDEN"""", USA COUNTRY OF MANUFACTURE: USTRADE MARK: ASTRAZENECA-KSIGDUO PROLONG, FILM-COATED TABLETS, PROLONGED ACTION OF 10/1000 MG, 7 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: DAPAGLIFLOZIN PROPANEDIOL 12.30 MG, WHICH IS EQUIVALENT TO 10 MG DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1005.04 MG) SERIES: TC0168 -360??-??????? PROLONG, TABLETS COVERED WITH A FILM COATING" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - KRESTOR, FILM-COATED TABLETS, 20 MG EACH, 14 TABLETS IN A BLISTER; 2 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 FILM-COATED TABLET, CONTAINS: 20 MG ROSUVASTATIN IN THE FORM OF 20.80 MG ROSUVASTATIN CALCIUM) SERIES: SH525-286UP MANUFACTURER: """"MANUFACTURER OF THE DRUG """"IN BULK"""": IPIER PHARMACEUTICALS INC., PUERTO RICO, USA; MANUFACTURER RESPONSIBLE FOR PACKAGING, CONTROL AND BATCH RELEASE: ASTRAZENECA UK LIMITED, GREAT BRITAIN"""", PUERTO RICO COUNTRY OF MANUFACTURE: PRTRADEMARK: ASTRAZENECA """ | |
|
PUERTO RICO | UKRAINE | 0 |
| 3004320000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, CONTAINING CORTICOSTEROID HORMONES, PACKAGED FOR RETAIL SALE: - PULMIKORT, SUSPENSION FOR SPRAYING, 0.25 MG/ML, 2 ML IN A CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 ML OF SUSPENSION FOR SPRAYING CONTAINS: 0.25 MG OF BUDESONIDE) SERIES: SEKW -780UP-PULMICORT, SUSPENSION FOR SPRAYING, 0.5 MG/ML OF 2 ML IN A CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 ML OF SPRAY SUSPENSION CONTAINS: 0.5 MG OF BUDESONIDE) SERIES: PEKH-1560UP-SYMBIKORT TURBUCHALER, POWDER FOR INHALATION, DOSED, 160 MCG/4.5 MCG/DOSE 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 INHALATION (DOSE) CONTAINS: 160 MCG OF MICRONIZED BUDESONIDE, 4.5 MCG OF FORMOTEROL FUMARATE DIHYDRATE) SERIES: XLSA -2880 UNITS MANUFACTURER: ""ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADE MARK: ASTRAZENECA-BUDESONIDE ASTRAZENECA , SUSPENSION FOR SPRAYING, 0.5 MG/ML, 2 ML IN A CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 ML SUSPENSION FOR SPRAYING CONTAINS: 0.5 MG BUDESONIDE) SERIES: PELM-780UP MANUFACTURER: ""PRODUCTION, QUALITY CONTROL AND RELEASE OF THE SERIES: ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADE MARK: ASTRAZENECA""" | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - BETALOK ZOK, FILM-COATED TABLETS WITH DELAYED RELEASE OF 100 MG, 30 TABLETS IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: 95 MG OF METOPROLOL SUCCINATE, WHICH CORRESPONDS TO 100 MG OF METOPROLOL TARTRATE) SERIES: VCAH-48UP-BRILINTA, TABLETS COVERED WITH A FILM COVER, 90 MG OF 14 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: TICAGRELOR 90 MG) SERIES: VHNS-150UP MANUFACTURER: ""ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADEMARK: ASTRAZENECA" | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - KRESTOR, FILM-COATED TABLETS, 10 MG OF 14 TABLETS IN A BLISTER PACK; 2 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET, COVERED WITH A FILM COVER, CONTAINS: 10 MG ROSUVASTATIN IN THE FORM OF 10.40 MG ROSUVASTATIN CALCIUM) SERIES: SJ816-140UP-KRESTOR, TABLETS COVERED WITH A FILM COVER, 20 MG EACH, 14 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 FILM-COATED TABLET, CONTAINS: 20 MG ROSUVASTATIN IN THE FORM OF 20.80 MG ROSUVASTATIN CALCIUM) SERIES: SK130-140UP-KRESTOR, FILM-COATED TABLETS, 40 MG OF 7 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET, COVERED WITH A FILM COVER, CONTAINS: 40 MG ROSUVASTATIN IN THE FORM OF 41.60 MG ROSUVASTATIN CALCIUM) SERIES: SK550-120UP-KRESTOR, TABLETS COVERED WITH A FILM COVER, 5 MG EACH, 14 TABLETS IN A BLISTER PACK; 2 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET, COVERED WITH A FILM COVER, CONTAINS: 5 MG ROSUVASTATIN IN THE FORM OF 5.20 MG ROSUVASTATIN CALCIUM) SERIES: SJ638-140UP MANUFACTURER: """"MANUFACTURER OF THE MEDICINAL PRODUCT """"IN BULK"""": IPIER PHARMACEUTICALS INC. ,PUERTO RICO, USA; MANUFACTURER RESPONSIBLE FOR PACKAGING, CONTROL AND BATCH RELEASE: ASTRAZENECA UK LIMITED, GREAT BRITAIN"""", PUERTO RICO COUNTRY OF MANUFACTURE: PRTRADEMARK: ASTRAZENECA""" | |
|
PUERTO RICO | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - KOMBOGLYZA XR, FILM-COATED TABLETS, 5 MG/1000 MG, 7 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET, COVERED WITH A FILM COVER, CONTAINS: 5.58 MG OF SAXAGLIPTIN HYDROCHLORIDE ANHYDROUS IN THE CALCULATION OF SAXAGLIPTIN 5 MG AND 1005 MG OF METFORMIN HYDROCHLORIDE IN THE CALCULATION OF METFORMIN 1000 MG) SERIES: TJ0092 -12 UNITS MANUFACTURER: ""ASTRAZENECA"" ""PHARMACEUTICALS LP"", USA, COUNTRY PRODUCTION: USTRADE MARK: ASTRAZENECA-XIGDUO PROLONG, FILM-COATED TABLETS, PROLONGED ACTION OF 10/1000 MG, 7 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: DAPAGLIFLOZIN PROPANEDIOL 12.30 MG, WHICH IS EQUIVALENT TO 10 MG DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1005.04 MG) SERIES: TF0222 -360UP-KSIGDUO PROLONG, FILM-COATED TABLETS, PROLONGED ACTION 5/1000MG BY 7 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: DAPAGLIFLOZIN PROPANEDIOL 6.15 MG, WHICH IS EQUIVALENT TO 5 MG DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1005.04 MG) SERIES: TF0224 -240 UNITS MANUFACTURER: """"IN-BULK PRODUCTION, QUALITY CONTROL, PRIMARY AND SECONDARY PACKAGING, ISSUE OF THE SERIES: ASTRAZENECA PHARMACEUTICALS LP"", USACOUNTRY OF MANUFACTURE: USTRADE MARK: ASTRAZENECA""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004490000 | 1. MEDICINAL PRODUCT CONTAINING ALKALOIDS, FOR THERAPEUTIC USE FOR HUMANS, PACKAGED FOR RETAIL SALE. MASTODINON®, TABLETS, 20 TABLETS IN A BLISTER, 3 BLISTERS IN A BOX, SERIES 0000193437 - 1500 PACKAGES. (1 TABLET CONTAINS: AGNUS CASTUS O (COMMON SEDGE) 162 MG; SAULORHULLUM THALICTROIDES D4 (STEM LEAF BASILICUM-LIKE) 81 MG; CYCLAMEN PURPURASCENS D4 (PURPLE VIOLET) 81 MG; STRYCHNOS IGNATIA D6 (BITTER BREASTWORT) 81 MG; IRIS VERSICOLOR D2 (VARIEGATED ROOSTER) 162 MG; LILIUM TIGRINUM D3 (TIGER LILY) 81 MG;) KANEFRON® N, FILM-COATED TABLETS OF 20 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX, SERIES 0000193855 -12000 PACKAGES. (1 TABLET CONTAINS DRIED MEDICINAL PLANTS IN THE FORM OF A POWDER: HERBS OF GOLDENROD ( HERBA CENTAURII) 18 MG, LOVAGE ROOT (RADIX LEVISTICI) 18 MG, ROSEMARY LEAVES (FOLIA ROSMARINI) 18 MG;) CYCLODINONE ®, FILM-COATED TABLETS, 15 TABLETS IN A BLISTER, 2 BLISTERS IN A CARDBOARD BOX, SERIES 0000194274 - 2100 PACKAGES. 1 TABLET CONTAINS 4 MG OF THE EXTRACT OF THE FRUITS OF THE ORDINARY NATIVE DRY GOOSEBERRY (FRUCTIS AGNI CASTI) (7-11:1), (EXTRACTANT ETHANOL 70% (V/V); TRADE MARK - BIONORICA. MANUFACTURER - BIONORICA SE. COUNTRY OF MANUFACTURE - DE. DO NOT CONTAIN NARCOTIC OR PSYCHOTROPIC COMPONENTS. NOT IN AN AEROSOL CAN.""" | |
|
GERMANY | UKRAINE | 0 |
| 3004500000 | 1. MEDICINAL PRODUCT FOR THERAPEUTIC USE FOR PEOPLE WITH VITAMIN CONTENT, PACKAGED FOR RETAIL SALE. SINUPRET®, FILM-COATED TABLETS, 25 TABLETS IN A BLISTER, 2 BLISTERS IN A CARDBOARD BOX, SERIES 0000190773 - 10500 PACKAGES. (1 TABLET CONTAINS DRIED MEDICINAL PLANTS IN THE FORM OF POWDER: GENTIAN ROOT (RADIX GENTIANAE) 6 MG, PRIMROSE FLOWER WITH CALYX (FLORES RIMULAE SUM СALYSIBUS) 18 MG, SORREL HERB (NERBA RUMISIS) 18 MG, ELDER FLOWER (FLORES SAMBUSI) 18 MG, VERBENA HERB (NERBA VERBENAE) ) 18 MG;) SINUPRET® EXTRACT, COATED TABLETS, 10 TABLETS IN A BLISTER, 2 BLISTERS IN A CARDBOARD BOX, SERIES 0000190935 - 3300 PACKAGES. (1 TABLET CONTAINS 160 MG OF DRY EXTRACT (3–6:1) OF GENTIAN ROOT (РАДИХ ГЕНТИАНЕ), PRIMROSE FLOWER WITH A CALYX (FLORES РИМУЛАЕ СУМ САЛИСИBUS), SORREL HERB (NERBA RUMISIS), ELDER FLOWER (FLORЕS SAMBUSI), VERBENA HERB (NERБА ВЕРБЕНАЕ) (1:3:3:3:3), (EXTRACTANT ETHANOL 51% (M/M)); SINUPRET®, SYRUP OF 100 ML IN A BOTTLE, 1 BOTTLE IN A BOX, SERIES 0000192151 - 2000 PACKAGES. (100 G OF SYRUP CONTAIN: 10 G OF EXTRACT (1:11) FROM GENTIAN ROOT ( РАДИХ ГЕНТИАНЕ), PRIMROSE FLOWER WITH A CUP (FLORES РИМУЛАЕ СУМ САЛИСИБУ), VERBENA HERB (NERБА ВЕРБЕНАЕ), SORREL HERB (NERBA RUMISIS), ELDER FLOWER (FLORЕС SAMBUSI) (1:3:3:3:3), (EXTRACTANT ETHANOL 59% (V/V)); SINUPRET® FORTE, FILM-COATED TABLETS, 20 TABLETS IN A BLISTER, 1 BLISTER IN A CARDBOARD BOX, SERIES 0000193495 - 10230 PACKAGES. (1 TABLET CONTAINS DRIED MEDICINAL PLANTS IN THE FORM OF POWDER: SORREL HERBS (NERBA RUMISIS) 36 MG; VERBENA HERB (NERBA VERBENAE) 36 MG; GENTIAN ROOT (РАДИХ ГЕНТИАНЕЕ) 12 MG; ELDER FLOWER (FLORES SAMBUSI) 36 MG; PRIMROSE FLOWER WITH A CALYX (FLORES PRIMULAE SUM САLYСIBUS) 36 MG;) SINUPRET® , ORAL DROPS, 100 ML OF SOLUTION IN A BOTTLE WITH A DOSING DROPPER ON TOP, WITH A SCREW CAP AND AN OPENING CONTROL RING, 1 BOTTLE IN A CARDBOARD BOX, SERIES 0000193613 - 3200 PACKAGES. (100 G OF DROPS CONTAIN 29 G OF EXTRACT (1: 11) FROM THE ROOT OF GENTIAN (RADIX GENTIANAE); A PRIMROSE FLOWER WITH A CUP (FLORES PRIMULAE SUM САLYСИBUS); SORREL HERB (NERBA RUMISIS); ELDER FLOWER (FLORES SAMBUSI); VERBENA HERB (NERBA VERBENAE) (1:3:3:3:3), (EXTRACTANT ETHANOL 59% (V/V)) TRADE MARK - BIONORICA. MANUFACTURER - BIONORICA SE. COUNTRY OF MANUFACTURE - DE. DO NOT CONTAIN NARCOTIC OR PSYCHOTROPIC COMPONENTS. NOT IN AN AEROSOL CAN.""" | |
|
GERMANY | UKRAINE | 0 |
| 3004320000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, CONTAINING CORTICOSTEROID HORMONES, PACKAGED FOR RETAIL SALE: - PULMIKORT, SUSPENSION FOR SPRAYING, 0.5 MG/ML IN 2 ML CONTAINERS; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 ML SUSPENSION FOR SPRAYING CONTAINS: 0.5 MG OF BUDESONIDE) SERIES: PEKH -780 UNITS - SYMBIKORT TURBUCHALER, INHALATION POWDER, DOSED, 160 MCG/4.5 MCG/DOSE OF 60 DOSES IN A PLASTIC INHALER; 1 INHALER IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 INHALATION (DOSE) CONTAINS: 160 MCG OF MICRONIZED BUDESONIDE, 4.5 MCG OF FORMOTEROL FUMARATE HYDRATE) SERIES: XLTC-400UP-SYMBIKORT TURBUCHALER, POWDER FOR INHALATION, DOSED, 80 MCG/4.5 MCG/DOSE OF 60 DOSES IN PLASTIC INHALER; 1 INHALER IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 INHALATION (DOSE) CONTAINS: 80 MCG OF MICRONIZED BUDESONIDE, 4.5 MCG OF FORMOTEROL FUMARATE DIHYDRATE) SERIES: LAYR -480 UNITS MANUFACTURER: ""ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADEMARK: ASTRAZENECA-BUDESONIDE ASTRAZENECA SUSPENSION FOR SPRAYING, 0.25 MG/ML, 2 ML IN A CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 ML OF SUSPENSION FOR SPRAYING CONTAINS: 0.25 MG OF BUDESONIDE) SERIES: SEKC-20UP-BUDESONIDE ASTRAZENECA, SUSPENSION FOR SPRAYING, 0.5 MG/ML OF 2 ML IN A CONTAINER; 5 CONTAINERS IN AN ENVELOPE; 4 ENVELOPES IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 ML SUSPENSION FOR SPRAYING CONTAINS: 0.5 MG BUDESONIDE) SERIES: PELM-200UP MANUFACTURER: ""PRODUCTION, QUALITY CONTROL AND RELEASE OF THE SERIES: ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADE MARK: ASTRAZENECA""" | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - BETALOK ZOK, FILM-COATED TABLETS WITH DELAYED RELEASE OF 100 MG, 30 TABLETS IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: 95 MG OF METOPROLOL SUCCINATE, WHICH CORRESPONDS TO 100 MG OF METOPROLOL TARTRATE) SERIES: VCAH-48UP-BETALOK ZOK, FILM-COATED TABLETS WITH DELAYED RELEASE OF 25 MG, 14 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: 23.75 MG OF METOPROLOL SUCCINATE, WHICH CORRESPONDS TO 25 MG OF METOPROLOL TARTRATE) SERIES: ZBAD-66UP-BRILINTA, TABLETS COVERED WITH A FILM COVER, 60 MG OF 14 TABLETS IN A BLISTER; 4 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET, COVERED WITH A FILM COVER, CONTAINS: 60 MG OF TICAGRELOR) SERIES: KEHB -30 PACK-BRILINTA, TABLETS COVERED WITH A FILM COVER, 90 MG EACH, 14 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: TICAGRELOR 90 MG) SERIES: VHNS-360UP MANUFACTURER: ""ASTRAZENECA AB"", SWEDEN COUNTRY OF MANUFACTURE: SETRADE MARK: ASTRAZENECA" | |
|
SWEDEN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - KRESTOR, FILM-COATED TABLETS, 10 MG OF 14 TABLETS IN A BLISTER PACK; 2 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET, COVERED WITH A FILM COVER, CONTAINS: 10 MG ROSUVASTATIN IN THE FORM OF 10.40 MG ROSUVASTATIN CALCIUM) SERIES: SJ816-140UP-KRESTOR, TABLETS COVERED WITH A FILM COVER, 20 MG EACH, 14 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 FILM-COATED TABLET, CONTAINS: 20 MG ROSUVASTATIN IN THE FORM OF 20.80 MG ROSUVASTATIN CALCIUM) SERIES: SK130-210UP-KRESTOR, FILM-COATED TABLETS, 5 MG EACH, 14 TABLETS IN A BLISTER PACK; 2 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET, COVERED WITH A FILM COVER, CONTAINS: 5 MG ROSUVASTATIN IN THE FORM OF 5.20 MG ROSUVASTATIN CALCIUM) SERIES: SJ638 -70 UNITS MANUFACTURER: """"MANUFACTURER OF THE DRUG """"IN BULK"""": IPIER PHARMACEUTICALS INC. ,PUERTO RICO, USA; MANUFACTURER RESPONSIBLE FOR PACKAGING, CONTROL AND BATCH RELEASE: ASTRAZENECA UK LIMITED, GREAT BRITAIN"""", PUERTO RICO COUNTRY OF MANUFACTURE: PRTRADEMARK: ASTRAZENECA""" | |
|
PUERTO RICO | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, THERAPEUTIC AND PROPHYLACTIC, PACKAGED FOR RETAIL SALE: - KSIGDUO PROLONG, FILM-COATED TABLETS, PROLONGED ACTION OF 10/1000 MG, 7 TABLETS IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: DAPAGLIFLOZIN PROPANEDIOL 12.30 MG, WHICH IS EQUIVALENT TO 10 MG DAPAGLIFLOZIN TAMETFORMIN HYDROCHLORIDE 1005.04 MG) SERIES: TF0222 -240 УП-КСИГДУО PROLONG, FILM-COATED TABLETS, PROLONGED ACTION OF 5/1000 MG, 7 TABLETS IN A BLISTER; 4 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: DAPAGLIFLOZIN PROPANEDIOL 6.15 MG, WHICH IS EQUIVALENT TO 5 MG DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1005.04 MG) SERIES: TF0224 -120 UNITS MANUFACTURER: """"IN-BULK PRODUCTION, QUALITY CONTROL, PRIMARY AND SECONDARY PACKAGING, ISSUE OF THE SERIES: ASTRAZENECA PHARMACEUTICALS LP"", USACOUNTRY OF MANUFACTURE: USTRADE MARK: ASTRAZENECA""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT FOR HUMANS, FOR THERAPEUTIC OR PROPHYLACTIC USE, IN DOSAGE FORM, PACKAGED FOR RETAIL TRADE, WITHOUT THE CONTENT OF PSYCHOTROPIC AND NARCOTIC SUBSTANCES, NOT IN AEROSOL PACKAGING, DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES: 7F0803, LORISTA, FILM-COATED TABLETS, REGISTERED IN THE MINISTRY OF HEALTH SHELL, 100 MG NO. 30 (10X3) IN BLISTERS - 400 PCS; 7G4163, NALGESIN FORTE, TABLETS COVERED WITH A FILM SHELL, 275 MG NO. 20, (10X2) IN BLISTERS - 1952 PCS; 7F1001, NALGESIN FORTE, TABLETS, COATED FILM-COATED, 550 MG NO. 10, (10X1) IN BLISTERS - 1024 PCS; 7F0932, NALGESIN, FILM-COATED TABLETS, 275 MG NO. 10, (10X1) IN BLISTERS - 896 PCS; MANUFACTURER: KRKA, DD, NOVO MESTO TRADEMARK: KRKA COUNTRY OF MANUFACTURE: SI | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 1704905500 | 1. REGISTERED IN THE MINISTRY OF HEALTH, A MEDICINAL PRODUCT FOR HUMANS, CONTAINING SUGAR AND PLANT EXTRACTS, FOR THERAPEUTIC OR PROPHYLACTIC USE, IN DOSAGE FORM, PACKAGED FOR RETAIL TRADE, WITHOUT THE CONTENT OF PSYCHOTROPIC AND NARCOTIC SUBSTANCES, DO NOT CONTAIN PRODUCTS OF ANIMAL ORIGIN: 7F9635, SEPTOLETE TOTAL EUCALYPTUS , LOLLIPOPS, 3 MG/1 MG NO. 16, 8 LOLLIPOPS IN A BLISTER; 2 BLISTERS IN A CARDBOARD BOX - 2772 PCS 7F6567, SEPTOLETE TOTAL LEMON AND ELDERBERRY, LOLLIPOPS, 3 MG/1 MG 8 LOLLIPOPS IN A BLISTER, 2 BLISTERS IN A BOX - 231 PCS; 7G6058, SEPTOLETE TOTAL LEMON AND ELDERBERRY, LOLLIPOPS, 3 MG /1 MG OF 8 LOLLIPOPS IN A BLISTER, 2 BLISTERS IN A BOX - 2184 PCS; 7F6568, SEPTOLETE TOTAL LEMON AND HONEY, LOLLIPOPS, 3 MG/1 MG OF 8 LOLLIPOPS IN A BLISTER, 2 BLISTERS IN A BOX - 1092 PCS; MANUFACTURER: KRKA, DD, NOVO MESTO TRADEMARK: KRKA COUNTRY OF MANUFACTURE: SI | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 2106909200 | 1. REGISTERED IN THE MINISTRY OF HEALTH, A MEDICINAL PRODUCT FOR HUMANS CONTAINING VITAMIN-MINERAL SUBSTANCES, WITHOUT THE CONTENT OF MILK FAT, SUCROSE, ISOGLUCOSE, GLUCOSE, STARCH, IN THE FORM OF TABLETS, PACKAGED FOR RETAIL TRADE, DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES: 7G0855, DUOVIT , TABLETS COVERED WITH A SHELL, COMBI-PACKAGING NO. 40, COMBI-PACKAGING: 5 TABLETS OF RED COLOR AND 5 TABLETS OF BLUE COLOR IN A BLISTER; 4 BLISTERS IN A CARDBOARD BOX - 80 PIECES MANUFACTURER: KRKA, DD, NOVO MESTO TRADEMARK: KRKA COUNTRY OF MANUFACTURE: SI | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 3004320000 | 1. A MEDICINAL PRODUCT FOR HUMANS, FOR THERAPEUTIC OR PROPHYLACTIC USE, IN DOSAGE FORM, CONTAINING CORTICOSTEROID HORMONES, THEIR DERIVATIVES OR STRUCTURAL ANALOGUES, PACKAGED FOR RETAIL SALE, WITHOUT THE CONTENT OF PSYCHOTROPIC AND NARCOTIC SUBSTANCES, NOT IN AEROSOL PACKAGING, DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES: 7F0991, KENALOG 40, SUSPENSION FOR INJECTIONS, 40 MG/ML NO. 5, 1 ML IN AN AMPOULE; 5 AMPOULES IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX - 160 PCS.; MANUFACTURER: KRKA, DD, NOVO MESTO TRADEMARK: KRKA COUNTRY OF MANUFACTURE: SI | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 3004200000 | 1. MEDICINAL PRODUCT FOR HUMANS, FOR THERAPEUTIC OR PROPHYLACTIC USE, CONTAINING ANTIBIOTICS, IN DOSAGE FORM, PACKAGED FOR RETAIL TRADE, WITHOUT THE CONTENT OF PSYCHOTROPIC AND NARCOTIC SUBSTANCES, NOT IN AEROSOL PACKAGING, DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES: 7F8460, FROMILID, REGISTERED IN THE MINISTRY OF HEALTH FILM-COATED TABLETS, 500 MG NO. 14 (7X2) IN A BLISTER PACK - 720 PCS.; MANUFACTURER: KRKA, DD, NOVO MESTO TRADE MARK: KRKA COUNTRY OF MANUFACTURE: SI; AT | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 3004900000 | 1. REGISTERED IN THE MINISTRY OF HEALTH, A MEDICINAL PRODUCT FOR HUMANS, FOR THERAPEUTIC OR PROPHYLACTIC USE, IN DOSAGE FORM, PACKAGED FOR RETAIL TRADE, WITHOUT PSYCHOTROPIC AND NARCOTIC SUBSTANCES, NOT IN AEROSOL PACKAGING, DOES NOT CONTAIN OZONE-DEPLETING SUBSTANCES: 7G3309, GLYCLADA, MODIFIED-RELEASE TABLETS 60 MG NO. 30 (15X2) - 3840 PCS; 7E0387, TORENDO, FILM-COATED TABLETS OF 2 MG NO. 60 (10X6) IN A BLISTER - 480 PCS; 7F1013, VAZILIP, FILM-COATED TABLETS, 20 MG NO. 28 (7X4) IN A BLISTER; - 1296 PCS; MANUFACTURER: KRKA, DD, NOVO MESTO BRAND: KRKA COUNTRY OF MANUFACTURE: SI | |
|
EUROPEAN UNION | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
Pp Konex frequently asked questions
You can explore detailed shipment records of Pp Konex through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to Pp Konex. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to Pp Konex, helping you expand your sourcing network.
Eximpedia’s trade data highlights Pp Konex’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand Pp Konex’s trade activities.
Traders can collaborate with Pp Konex by contacting them through their official channels or visiting their headquarters for detailed trade discussions.